Unicycive Therapeutics, Inc.

NasdaqCM:UNCY Stock Report

Market Cap: US$42.1m

Unicycive Therapeutics Balance Sheet Health

Financial Health criteria checks 3/6

Unicycive Therapeutics has a total shareholder equity of $-3.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $14.2M and $18.0M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$9.70m
Equity-US$3.81m
Total liabilitiesUS$18.00m
Total assetsUS$14.19m

Recent financial health updates

Will Unicycive Therapeutics (NASDAQ:UNCY) Spend Its Cash Wisely?

Feb 16
Will Unicycive Therapeutics (NASDAQ:UNCY) Spend Its Cash Wisely?

We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate

Aug 18
We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate

Unicycive Therapeutics (NASDAQ:UNCY) Will Have To Spend Its Cash Wisely

Mar 08
Unicycive Therapeutics (NASDAQ:UNCY) Will Have To Spend Its Cash Wisely

Recent updates

Will Unicycive Therapeutics (NASDAQ:UNCY) Spend Its Cash Wisely?

Feb 16
Will Unicycive Therapeutics (NASDAQ:UNCY) Spend Its Cash Wisely?

We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate

Aug 18
We're Keeping An Eye On Unicycive Therapeutics' (NASDAQ:UNCY) Cash Burn Rate

Unicycive Therapeutics (NASDAQ:UNCY) Will Have To Spend Its Cash Wisely

Mar 08
Unicycive Therapeutics (NASDAQ:UNCY) Will Have To Spend Its Cash Wisely

Unicycive stock soars 25% as kidney drug UNI-494 shows promise in preclinical study in rats

Sep 07

Unicycive Therapeutics GAAP EPS of -$0.24

Aug 16

Unicycive inks licensing deal for kidney disease drug Renazorb in Asia

Jul 18

Financial Position Analysis

Short Term Liabilities: UNCY has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: UNCY has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: UNCY is debt free.

Reducing Debt: UNCY's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: UNCY has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: UNCY is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.